Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|9|1|94-100
ISSN： 1389-4501
Source： Current Drug Targets, Vol.9, Iss.1, 2008-01, pp. : 94-100
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. :
Access to resources
Recommend
Duloxetine in diabetic neuropathy
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. :
Emerging drugs for diabetic neuropathy
By Tahrani Abd A Askwith Trevor Stevens Martin J
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
C-peptide and diabetic neuropathy
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. :